|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-3-23
|
|
pubmed:abstractText |
The European trial on Reduction Of cardiac events with Perindopril in patients with stable coronary Artery disease (EUROPA) demonstrated the benefits of perindopril with respect to secondary prevention of cardiovascular risk in patients with stable coronary artery disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1875-2136
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
102
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
89-96
|
|
pubmed:dateRevised |
2011-4-25
|
|
pubmed:meshHeading |
pubmed-meshheading:19303575-Aged,
pubmed-meshheading:19303575-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:19303575-Coronary Artery Disease,
pubmed-meshheading:19303575-Double-Blind Method,
pubmed-meshheading:19303575-Europe,
pubmed-meshheading:19303575-Female,
pubmed-meshheading:19303575-Humans,
pubmed-meshheading:19303575-Kaplan-Meier Estimate,
pubmed-meshheading:19303575-Male,
pubmed-meshheading:19303575-Middle Aged,
pubmed-meshheading:19303575-Myocardial Infarction,
pubmed-meshheading:19303575-Myocardial Revascularization,
pubmed-meshheading:19303575-Perindopril,
pubmed-meshheading:19303575-Proportional Hazards Models,
pubmed-meshheading:19303575-Risk Assessment,
pubmed-meshheading:19303575-Risk Factors,
pubmed-meshheading:19303575-Secondary Prevention,
pubmed-meshheading:19303575-Time Factors,
pubmed-meshheading:19303575-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial.
|
|
pubmed:affiliation |
Hôpital cardiologique, boulevard du Prof.-Leclercq, 59037 Lille, France.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
